Tilray Brands (TLRY) EBT (2017 - 2026)
Tilray Brands' (TLRY) quarterly EBT came in at -$51.4 million in Q2 2026, up 96.31% YoY from -$26.2 million in Q2 2025, and down 120.83% on a QoQ basis from -$23.3 million in Q1 2026.
Tilray Brands (TLRY) EBT (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of EBT data on file, last reported at -$51.4 million in Q2 2026.
- Quarterly EBT rose 96.31% year-over-year to -$51.4 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$115.4 million (up 94.99% YoY) and the FY2026 annual result came in at -$115.4 million, up 94.99% from the prior year.
- EBT declined to -$51.4 million in Q2 2026, from -$23.3 million in the prior quarter.
- In the past five years, EBT ranged from a high of $50.6 million in Q1 2022 to a low of -$1.4 billion in Q2 2025.
- A 5-year average of -$251.5 million and a median of -$55.0 million in 2022 frame the typical range for EBT.
- The widest YoY moves for EBT: up 120.07% in 2022, down 58312.7% in 2022.
- Tracing TLRY's EBT over 5 years: stood at -$73.3 million in 2022, then surged by 32.43% to -$49.6 million in 2023, then sank by 67.95% to -$83.2 million in 2024, then jumped by 51.99% to -$40.0 million in 2025, then fell by 28.53% to -$51.4 million in 2026.
- The last three EBT figures came in at -$51.4 million (Q2 2026), -$23.3 million (Q1 2026), and -$40.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Tilray Brands | 514.99 Mn | 280.36 Mn | 90.52 Mn | -51.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -51.36 Mn |
| Feb 28, 2026 | -23.26 Mn |
| Nov 30, 2025 | -39.96 Mn |
| Aug 31, 2025 | -772,000.00 |
| May 31, 2025 | -1.39 Bn |
| Feb 28, 2025 | -792.33 Mn |
| Nov 30, 2024 | -83.24 Mn |
| Aug 31, 2024 | -33.77 Mn |
| May 31, 2024 | -43.00 Mn |
| Feb 29, 2024 | -107.85 Mn |
| Nov 30, 2023 | -49.56 Mn |
| Aug 31, 2023 | -48.60 Mn |
| May 31, 2023 | -111.69 Mn |
| Feb 28, 2023 | -1.21 Bn |
| Nov 30, 2022 | -73.35 Mn |
| Aug 31, 2022 | -58.58 Mn |
| May 31, 2022 | -461.60 Mn |
| Feb 28, 2022 | 50.65 Mn |
| Nov 30, 2021 | 126,000.00 |
| Aug 31, 2021 | -29.84 Mn |